Atox Bio For Profit
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as ischemia/reperfusion injuries. The company was founded in 2003 and headquartered in HaMerkaz, Israel.
Funding Status:
Late Stage Venture
Headquarters:
Ness Ziona, HaMerkaz, Israel
Founded Date:
2003
Employee Number:
30
Estimated Revenue:
$5.0M
Industry:
Clinical Data Management
Technology:
Participatory medicine
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A